Oblenio Bio
PrivateLast Round
Series B
Jun 25, 2026
Total Funding Raised
$62M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Oblenio Bio operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series B round in June 2026.
Oblenio Bio is a biotechnology company developing LBL-051, a tri-specific T-cell engager antibody, for the treatment of autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oblenio Bio Comparables
Compare Oblenio Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Boulevard Bio | 91% | |
| Kali Therapeutics | 86% | |
| Gilead Sciences | 82% |
For institutional investors. Book with your work email.
Oblenio Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 25, 2026 | ||||
| Series A | Nov 7, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Oblenio Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aditum Bio | Series B, Series A |
| GV | Series B |
| Deep Track Capital | Series B |
| Pfizer Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors grew 93% MoM.
- Sep 3, 2026
Grew 100% QoQ from 5 to 10 employees.
For institutional investors. Book with your work email.
Oblenio Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Oblenio Bio's valuation, stock price, and market status.
Is Oblenio Bio a public or private company?
Oblenio Bio is a private company.
What is the current stock price of Oblenio Bio?
Oblenio Bio is a private company, so its shares have no public market price. Caplight tracks Oblenio Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Oblenio Bio worth (valuation)?
Valuation information for Oblenio Bio is not publicly available.
Can I buy Oblenio Bio stock?
Oblenio Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Oblenio Bio's last funding round?
Oblenio Bio's most recent funding round was Series B on June 25, 2026.
Who are the main investors in Oblenio Bio?
Key investors in Oblenio Bio include Aditum Bio, Pfizer Ventures.
Will Oblenio Bio IPO soon?
No public IPO plans have been announced for Oblenio Bio.
How can I track Oblenio Bio secondary market activity?
Caplight tracks bids, offers, and trades in Oblenio Bio's shares on secondary markets.